Growth ⏱ Half-life: Short — approximately 30 minutes. Multiple daily doses used in research protocols.

Fragment 176-191

HGH Fragment 176-191

Buy from $34.99 →
Half-Life
Short — approximately 30 minutes. Multiple daily doses used in research protocols.
Mol. Weight
1817.12 g/mol

What is Fragment 176-191?

HGH Fragment 176-191 is the naturally occurring C-terminal portion of human growth hormone that contains the fat-metabolic signaling region. It represents the minimal active sequence for GH-mediated lipolysis without the growth-promoting or diabetogenic effects of the full hormone.

Research Applications

Fat metabolism, lipolysis signaling, body composition research without IGF-1 elevation, and comparative studies with AOD-9604.

Dosage Information (Research Use)

Research protocols: 250-500 mcg subcutaneously, 1-2 times daily, typically on an empty stomach. Research use only.

Reconstitution & Handling

Standard BAC water reconstitution.

Half-Life & Pharmacokinetics

Short — approximately 30 minutes. Multiple daily doses used in research protocols.

Reported Observations in Literature

Generally well-tolerated. Injection site irritation reported. No significant effects on glucose or IGF-1.

Key Research References

  • Wu Z, et al. “The C-terminal fragment 177-191 of growth hormone has lipolytic effects.” Biochem Biophys Res Commun. 1993

How Fragment 176-191 Works

Fragment 176-191 is the unmodified C-terminal segment of human growth hormone responsible for the lipolytic (fat-burning) activity of the full hormone. Unlike AOD-9604 (which adds a tyrosine residue), this is the native sequence fragment.

Research Findings

Studied alongside AOD-9604 in fat metabolism research. Does not elevate IGF-1 or affect blood glucose in published data.

Dosage & Administration

Research protocols: 250-500 mcg subcutaneously, 1-2 times daily, typically on an empty stomach. Research use only.

Safety & Side Effects

Generally well-tolerated. Injection site irritation reported. No significant effects on glucose or IGF-1.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Molecular Weight 1817.12 g/mol
Half-Life Short — approximately 30 minutes. Multiple daily doses used in research protocols.
Available Sizes 2mg, 5mg
Storage Lyophilized: -20°C. Reconstituted: 2-8°C.

Key Research References

  • Wu Z, et al. "The C-terminal fragment 177-191 of growth hormone has lipolytic effects." Biochem Biophys Res Commun. 1993

Get Fragment 176-191 from SourcePeptides

Third-party tested • Research-grade purity • Fast US shipping

Shop Now →

Related Peptides

View all →
Growth
Long-acting GHRH analog with albumin-binding DAC extension for sustained GH elevation over 8+ days per injection.
Growth
Modified fragment of human growth hormone (hGH 176-191) researched specifically for fat metabolism without GH-related side effects.
Growth
Growth hormone releasing hormone analog that stimulates pulsatile GH secretion for sustained elevation of growth hormone and IGF-1.